Responses
Clinical/translational cancer immunotherapy
Original research
First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial
Compose a Response to This Article
Other responses
No responses have been published for this article.
